ArticleTherapeutic advances in chronic disease2022

Nicotinamide supplementation in diabetic nonalcoholic fatty liver disease patients: randomized controlled trial.

Rasha R El-Kady et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.